HBIO.US Harvard Bioscience Inc

Healthcare Life Sciences Tools & Services USA Stocks
9.39 USD
Close of Nov 15, 2026
4.00 10.20
Market cap
USD 42.9M
P/E
-
P/B
8.49x
ROE
-233.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is HBIO.US undervalued?

Graham number

The Graham number of Harvard Bioscience Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Harvard Bioscience Inc fundamental analysis

No fundamental analysis for Harvard Bioscience Inc yet.

Harvard Bioscience Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Harvard Bioscience Inc

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and pr…

Full company profile